Skip to content
All news
Analysis

Citi Raises Lam Research Target to $450 on Chip Boom

Citi raised its price target on Lam Research (NASDAQ:LRCX) by $135 to $450, part of a broader upgrade for semiconductor equipment makers. The move reflects expectations of a multi-year boom in chip manufacturing investments.

June 29, 2026
2 min read
Source: Insider Monkey
Share:

Key Numbers

new target
$450
old target
$315
increase
$135

On June 17, Citi raised its price target on Lam Research Corporation (NASDAQ:LRCX) to $450 from $315, a $135 increase. The revision is part of a series of similar upgrades for several semiconductor equipment companies, as analysts anticipate a multi-year investment surge in chip fabrication.

Recommendation Change

  • Previous Target: $315
  • New Target: $450
  • Increase: $135
  • Rating: Not explicitly changed, but the target hike implies a bullish outlook.

Analyst Rationale

Citi's analyst believes Lam Research will benefit from massive investments in new chip fabrication plants, driven by government initiatives and corporate efforts to boost domestic production capacity. Growing demand for memory chips and advanced technologies further supports the company's prospects.

Context

This upgrade follows a wave of target price increases from multiple investment banks for semiconductor equipment makers such as Tokyo Electron (TEL) and KLA Corporation (KLAC). Lam Research shares have risen about 25% year-to-date, buoyed by market optimism over the sector's capital expenditure cycle.

What This Means for Investors

The target price hike reflects positive long-term expectations for the semiconductor equipment sector. However, investors should consider the cyclical nature of the industry and geopolitical risks that could impact supply chains.

Frequently Asked Questions

Citi raised the target by $135 from $315 to $450.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.